Aspinity Welcomes Semiconductor Industry Veteran Richard Hegberg as CEO
![forbes](https://www.anzupartners.com/wp-content/uploads/2023/11/Forbes.png)
The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors
The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors